Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decision Making: P-value Method01:09

Decision Making: P-value Method

The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Decision Making: Traditional Method01:14

Decision Making: Traditional Method

The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Econometric Views (EViews)01:29

Econometric Views (EViews)

Econometric Views, often stylized as EViews, is a package that merges statistical analysis with econometric studies. It is designed to provide tools for time series analysis, forecasting, and econometric model simulation. The software originated from MicroTSP software and has evolved significantly since its inception in 1981. The history of EViews is marked by a continuous effort to enhance its computational speed and user interface. It was initially developed for large computing systems but...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Locally advanced breast implant-associated anaplastic large-cell lymphoma: a combined medical-surgical approach.

European review for medical and pharmacological sciences·2021
Same author

Danish heart patients' participation in and experience with rehabilitation.

Scandinavian journal of public health·2012
Same author

Cost-effectiveness of erlotinib versus docetaxel for second-line treatment of advanced non-small-cell lung cancer in the United Kingdom.

The Journal of international medical research·2010
Same author

Effects of socioeconomic status on the physical activity in adolescents: a systematic review of the evidence.

Scandinavian journal of medicine & science in sports·2010
Same author

[Usefulness of determining urinary trypsinogen-2 in diagnosis and prognosis of patients with acute pancreatitis].

Anales del sistema sanitario de Navarra·2010
Same author

Responsiveness of observer rating scales by analysis of number of days until improvement in patients with major depression.

European psychiatry : the journal of the Association of European Psychiatrists·2009

Related Experiment Video

Updated: Jul 13, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

The Danish approach to standards for economic evaluation methodologies.

A Alban1, M Gyldmark, A V Pedersen

  • 1Danish Institute for Health Services Research and Development, Copenhagen, Denmark. dsi@dsi.dk

Pharmacoeconomics
|November 3, 1997
PubMed
Summary

Denmark is exploring economic evaluation methods for healthcare decision-making. A voluntary program for pharmaceutical products will be introduced to assess feasibility and desirability of standardized economic evaluations.

More Related Videos

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

Related Experiment Videos

Last Updated: Jul 13, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

Area of Science:

  • Health Economics
  • Health Services Research
  • Policy Analysis

Background:

  • International standards for economic evaluation in healthcare are emerging.
  • A 1994 report assessed the readiness of economic evaluation methods for Danish healthcare decision-making.
  • This article examines the Danish context regarding economic evaluation of medical technologies and services.

Purpose of the Study:

  • To evaluate the attitude towards economic evaluation in Denmark.
  • To identify application areas for economic evaluation.
  • To assess the desirability and feasibility of standardized methods for economic evaluations in Danish healthcare.

Main Methods:

  • Review of the state-of-the-art in economic evaluation methodologies.
  • Analysis of a report commissioned by Danish health authorities.
  • Consideration of a roundtable discussion with stakeholders.

Main Results:

  • The Danish health authorities decided to implement economic evaluation for new pharmaceutical products.
  • This implementation will be voluntary for an initial period of 2-3 years.
  • The decision follows a review of existing methodologies and stakeholder input.

Conclusions:

  • Denmark is moving towards incorporating economic evaluation into healthcare policy.
  • A phased, voluntary approach is adopted for pharmaceutical reimbursement decisions.
  • Further assessment is needed on the feasibility and desirability of standardized methods.